John M Leonard Intellia Therapeutics, Inc. (NTLA) insider trading activity

John M Leonard is President and CEO of Intellia Therapeutics, Inc.. Currently has a direct ownership of 960,072 shares of NTLA, which is worth approximately $21.2 Million. The most recent transaction as insider was on Mar 01, 2024, when has been sold 113,586 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 960K

0% 3M change

11.91% 12M change

Total Value Held $21.2 Million

JOHN M LEONARD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2024	BUY Grant, award, or other acquisition	-	113,586 Added 10.58%	960,072 Common Stock
Jan 03 2024	SELL Open market or private sale	$566,309 $29.46 p/Share	19,223 Reduced 2.22%	846,486 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	7,848 Added 0.9%	865,709 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	91,036 Added 9.59%	857,861 Common Stock
Jan 04 2023	SELL Open market or private sale	$248,302 $37.21 p/Share	6,673 Reduced 0.86%	766,825 Common Stock
Jan 01 2023	BUY Exercise of conversion of derivative security	-	7,848 Added 1.0%	773,498 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	40,990 Added 5.08%	765,650 Common Stock
Jan 01 2022	SELL Open market or private sale	$279,839 $112.25 p/Share	2,493 Reduced 0.34%	724,660 Common Stock
Jan 01 2022	BUY Exercise of conversion of derivative security	-	7,848 Added 1.07%	727,153 Common Stock
Sep 01 2021	SELL Open market or private sale	$7,604,950 $170.0 p/Share	44,735 Reduced 5.86%	719,305 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$934,067 $20.88 p/Share	44,735 Added 5.53%	764,040 Common Stock
Aug 31 2021	SELL Open market or private sale	$5,864,115 $155.0 p/Share	37,833 Reduced 5.0%	719,305 Common Stock
Aug 31 2021	BUY Exercise of conversion of derivative security	$551,605 $14.58 p/Share	37,833 Added 4.76%	757,138 Common Stock
Aug 30 2021	SELL Open market or private sale	$6,086,795 $156.86 p/Share	38,804 Reduced 5.12%	719,305 Common Stock
Aug 30 2021	BUY Exercise of conversion of derivative security	$542,868 $13.99 p/Share	38,804 Added 4.87%	758,109 Common Stock
Aug 23 2021	SELL Open market or private sale	$4,144,397 $152.71 p/Share	27,139 Reduced 3.64%	719,305 Common Stock
Aug 23 2021	BUY Exercise of conversion of derivative security	$363,663 $13.4 p/Share	27,139 Added 3.51%	746,444 Common Stock
Aug 19 2021	SELL Open market or private sale	$3,434,962 $151.44 p/Share	22,682 Reduced 3.06%	719,305 Common Stock
Aug 19 2021	BUY Exercise of conversion of derivative security	$303,939 $13.4 p/Share	22,682 Added 2.97%	741,987 Common Stock
Apr 13 2021	BUY Exercise of conversion of derivative security	$268,707 $10.36 p/Share	25,937 Added 3.48%	719,305 Common Stock
Apr 01 2021	SELL Open market or private sale	$3,190,452 $83.5 p/Share	38,209 Reduced 5.22%	693,368 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$993,864 $13.99 p/Share	71,041 Added 9.13%	707,263 Common Stock
Feb 09 2021	SELL Open market or private sale	$2,103,225 $75.0 p/Share	28,043 Reduced 4.07%	660,536 Common Stock
Feb 09 2021	BUY Exercise of conversion of derivative security	$387,384 $6.83 p/Share	56,718 Added 7.61%	688,579 Common Stock
Feb 05 2021	SELL Open market or private sale	$1,558,680 $67.94 p/Share	22,942 Reduced 3.5%	631,861 Common Stock

Also insider at

IQV

IQVIA HOLDINGS INC. Healthcare

Director

JML

John M Leonard

President and CEO

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Value

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Intellia Therapeutics, Inc.

Track Activities on NTLA

Account